Hengmiao (Henry) Cheng

Title: Innovations of Hengmiao (Henry) Cheng

Introduction

Hengmiao (Henry) Cheng is a notable inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that modulate glucocorticoid receptor activity. With a total of 3 patents to his name, Cheng's work is paving the way for advancements in medical treatments.

Latest Patents

Cheng's latest patents include innovative tricyclic compounds and their compositions. One of his notable inventions is directed to compounds of Formula I, or salts thereof, which serve as modulators of the glucocorticoid receptor. These compounds and their salts are particularly useful in treating conditions mediated by glucocorticoid receptor activity. This research highlights the potential for new therapeutic approaches in managing various health conditions.

Career Highlights

Hengmiao (Henry) Cheng is currently employed at Pfizer Corporation, a leading global biopharmaceutical company. His work at Pfizer allows him to collaborate with some of the brightest minds in the industry, contributing to groundbreaking research and development in pharmaceuticals.

Collaborations

Cheng has worked alongside talented colleagues such as Rajesh Devraj and Gary A Decresenzo. Their collaborative efforts have further enhanced the innovative research being conducted at Pfizer.

Conclusion

Hengmiao (Henry) Cheng's contributions to the field of pharmaceutical sciences through his patents and collaborations are noteworthy. His work continues to influence the development of new treatments, showcasing the importance of innovation in healthcare.